| Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012 |
| Publication Date |
Apr 2012 |
| Publisher |
GlobalData |
| Product Type |
Report |
| Pages |
101 |
| Single User License |
$
1000.00 |
| Site User License |
$
2000.00 |
| Corporate User License |
$
3000.00 |
|
|
Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase. |
Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012" provides data on the Mild Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Mild Cognitive Impairment Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Mild Cognitive Impairment , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Mild Cognitive Impairment 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Mild Cognitive Impairment 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Mild Cognitive Impairment Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Posit Science Corporation 34
Clinical Trial Overview of Posit Science Corporation 34
Avid Radiopharmaceuticals, Inc. 35
Clinical Trial Overview of Avid Radiopharmaceuticals, Inc. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
GE Healthcare 39
Clinical Trial Overview of GE Healthcare 39
Chiesi Farmaceutici SpA 40
Clinical Trial Overview of Chiesi Farmaceutici SpA 40
Allon Therapeutics Inc. 41
Clinical Trial Overview of Allon Therapeutics Inc. 41
Eisai Inc. 42
Clinical Trial Overview of Eisai Inc. 42
Dr. Willmar Schwabe GmbH & Co. KG 43
Clinical Trial Overview of Dr. Willmar Schwabe GmbH & Co. KG 43
Avraham Pharmaceuticals Ltd. 44
Clinical Trial Overview of Avraham Pharmaceuticals Ltd. 44
Martek Biosciences Corporation 45
Clinical Trial Overview of Martek Biosciences Corporation 45
Astellas Pharma Inc. 46
Clinical Trial Overview of Astellas Pharma Inc. 46
Lahey Clinic Foundation, Inc. 47
Clinical Trial Overview of Lahey Clinic Foundation, Inc. 47
Merz Pharmaceuticals, LLC 48
Clinical Trial Overview of Merz Pharmaceuticals, LLC 48
Cortex Pharmaceuticals, Inc. 49
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 49
Memory Pharmaceuticals Corp. 50
Clinical Trial Overview of Memory Pharmaceuticals Corp. 50
Healthways, Inc. 51
Clinical Trial Overview of Healthways, Inc. 51
Bayer AG 52
Clinical Trial Overview of Bayer AG 52
Shire Plc 53
Clinical Trial Overview of Shire Plc 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Vanderbilt University 54
Clinical Trial Overview of Vanderbilt University 54
University of Washington 55
Clinical Trial Overview of University of Washington 55
University Hospital Basel 56
Clinical Trial Overview of University Hospital Basel 56
University Hospital, Angers 57
Clinical Trial Overview of University Hospital, Angers 57
Yale University 58
Clinical Trial Overview of Yale University 58
Radboud University 59
Clinical Trial Overview of Radboud University 59
Charite University 60
Clinical Trial Overview of Charite University 60
Johns Hopkins University 61
Clinical Trial Overview of Johns Hopkins University 61
Assistance Publique - Hopitaux de Paris 62
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 62
Emory University 63
Clinical Trial Overview of Emory University 63
Case Comprehensive Cancer Center 64
Clinical Trial Overview of Case Comprehensive Cancer Center 64
Mount Sinai School of Medicine 65
Clinical Trial Overview of Mount Sinai School of Medicine 65
Union College 66
Clinical Trial Overview of Union College 66
Swinburne University of Technology 67
Clinical Trial Overview of Swinburne University of Technology 67
University of Rochester 68
Clinical Trial Overview of University of Rochester 68
Maastricht University Medical Center 69
Clinical Trial Overview of Maastricht University Medical Center 69
Monash University 70
Clinical Trial Overview of Monash University 70
Wageningen University 71
Clinical Trial Overview of Wageningen University 71
University of Pennsylvania 72
Clinical Trial Overview of University of Pennsylvania 72
Centre Hospitalier Universitaire de Nice 73
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 73
Five Key Clinical Profiles 74
Appendix 99
Abbreviations 99
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 101
List of TablesList of Tables
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Mild Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Mild Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Mild Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Mild Cognitive Impairment Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Mild Cognitive Impairment Therapeutics Clinical Trials, G7 Countries, 2012* 18
Mild Cognitive Impairment Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Mild Cognitive Impairment Therapeutics Clinical Trials, E7 Countries, 2012* 20
Mild Cognitive Impairment Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Mild Cognitive Impairment Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Mild Cognitive Impairment Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Mild Cognitive Impairment Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Posit Science Corporation, 2012* 34
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Avid Radiopharmaceuticals, Inc., 2012* 35
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 36
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 37
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 38
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2012* 39
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2012* 40
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Allon Therapeutics Inc., 2012* 41
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 42
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe GmbH & Co. KG, 2012* 43
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Avraham Pharmaceuticals Ltd., 2012* 44
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Martek Biosciences Corporation, 2012* 45
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 46
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Lahey Clinic Foundation, Inc., 2012* 47
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharmaceuticals, LLC, 2012* 48
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2012* 49
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Memory Pharmaceuticals Corp., 2012* 50
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthways, Inc., 2012* 51
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 52
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2012* 53
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 54
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2012* 55
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012* 56
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2012* 57
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 58
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 59
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 60
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 61
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 62
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 63
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 64
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 65
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Union College, 2012* 66
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Swinburne University of Technology, 2012* 67
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2012* 68
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012* 69
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Monash University, 2012* 70
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Wageningen University, 2012* 71
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 72
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2012* 73
List of FiguresList of Figures
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Mild Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Mild Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Mild Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Mild Cognitive Impairment Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Mild Cognitive Impairment Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Mild Cognitive Impairment Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Mild Cognitive Impairment Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Mild Cognitive Impairment Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
GlobalData Methodology 100
| Title |
Date |
Price |
|
|
Jan 2013 |
$2000.00 |
|
|
Oct 2009 |
$149.00 |
|
|
Oct 2009 |
$149.00 |
| 2011 U.S. Offices of Dentists Industry Report |
| By Barnes Reports |
| The Offices of Dentists Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2011 current and 2012 f ...Read More
|
|
Oct 2010 |
$149.00 |
|
|
May 2011 |
$149.00 |
|
|
Oct 2010 |
$149.00 |
|
|
May 2011 |
$149.00 |
|
|
Apr 2011 |
$149.00 |
|
|
Oct 2010 |
$149.00 |
|
|
May 2011 |
$149.00 |
|
| |
|
|
|
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
|
|
|
| |
|
| |
|
|
|
